Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.

IF 1.1 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Future cardiology Pub Date : 2026-07-01 Epub Date: 2026-06-18 DOI:10.1080/14796678.2026.2689421
Tan Duy Nguyen, Mai Thi Tuyet Tran, Hanh Ngoc Huynh, Cuong Thao Lam
{"title":"Endovascular revascularisation of lower-extremity peripheral arterial disease: technical and clinical outcomes in a Vietnamese single-center prospective cohort study.","authors":"Tan Duy Nguyen, Mai Thi Tuyet Tran, Hanh Ngoc Huynh, Cuong Thao Lam","doi":"10.1080/14796678.2026.2689421","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To characterize lesion distribution, procedural strategy, and short-term outcomes after endovascular revascularisation for symptomatic lower-extremity peripheral arterial disease (PAD) in routine Vietnamese practice.</p><p><strong>Materials and methods: </strong>This prospective observational cohort included 336 consecutive patients with symptomatic lower-extremity PAD who underwent endovascular revascularisation at a Vietnamese tertiary center from January 2019 to January 2025. Lesions were classified across aorto-iliac, femoropopliteal, and infrapopliteal segments using a TASC-based framework. Outcomes were assessed post-procedure and at 30 days, 3 months, and 6 months.</p><p><strong>Results: </strong>Two-level disease was the most common anatomical pattern (47.3%), followed by three-level disease (36.0%). Contralateral femoral access was most frequently used (39.6%), and drug-coated balloons were the most common device strategy (63.7%). Technical success was achieved in 82.4% (95% CI 78.0-86.1). Access-site complications occurred in 5.7% (95% CI 3.6-8.7), in-hospital mortality was 2.9% (95% CI 1.6-5.4), and immediate hemodynamic success was 82.4% (95% CI 78.0-86.1). Landmark-based restenosis rates were 17.9%, 12.4%, and 24.7% at 30 days, 3 months, and 6 months, respectively.</p><p><strong>Conclusions: </strong>Endovascular revascularisation was feasible in this real-world Vietnamese PAD cohort, but restenosis remained frequent, supporting structured post-procedural surveillance.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"707-716"},"PeriodicalIF":1.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540240/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2026.2689421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To characterize lesion distribution, procedural strategy, and short-term outcomes after endovascular revascularisation for symptomatic lower-extremity peripheral arterial disease (PAD) in routine Vietnamese practice.

Materials and methods: This prospective observational cohort included 336 consecutive patients with symptomatic lower-extremity PAD who underwent endovascular revascularisation at a Vietnamese tertiary center from January 2019 to January 2025. Lesions were classified across aorto-iliac, femoropopliteal, and infrapopliteal segments using a TASC-based framework. Outcomes were assessed post-procedure and at 30 days, 3 months, and 6 months.

Results: Two-level disease was the most common anatomical pattern (47.3%), followed by three-level disease (36.0%). Contralateral femoral access was most frequently used (39.6%), and drug-coated balloons were the most common device strategy (63.7%). Technical success was achieved in 82.4% (95% CI 78.0-86.1). Access-site complications occurred in 5.7% (95% CI 3.6-8.7), in-hospital mortality was 2.9% (95% CI 1.6-5.4), and immediate hemodynamic success was 82.4% (95% CI 78.0-86.1). Landmark-based restenosis rates were 17.9%, 12.4%, and 24.7% at 30 days, 3 months, and 6 months, respectively.

Conclusions: Endovascular revascularisation was feasible in this real-world Vietnamese PAD cohort, but restenosis remained frequent, supporting structured post-procedural surveillance.

下肢外周动脉疾病的血管内重建:越南单中心前瞻性队列研究的技术和临床结果
目的:在越南常规实践中描述症状性下肢外周动脉疾病(PAD)的病变分布、手术策略和血管内血管重建术后的短期结果。材料和方法:该前瞻性观察队列包括336例有症状的下肢PAD患者,这些患者于2019年1月至2025年1月在越南三级中心接受了血管内重建术。使用基于tasc的框架将病变分为主动脉-髂段、股腘段和股腘下段。在手术后、30天、3个月和6个月时评估结果。结果:二级病变最常见(47.3%),三级病变次之(36.0%)。对侧股骨入路最常用(39.6%),药物包被球囊是最常用的装置策略(63.7%)。技术成功率为82.4% (95% CI 78.0-86.1)。通路部位并发症发生率为5.7% (95% CI 3.6-8.7),住院死亡率为2.9% (95% CI 1.6-5.4),即时血流动力学成功率为82.4% (95% CI 78.0-86.1)。在30天、3个月和6个月时,地标性再狭窄率分别为17.9%、12.4%和24.7%。结论:在越南PAD队列中,血管内血管重建是可行的,但再狭窄仍然频繁,支持结构化的术后监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future cardiology
Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.80
自引率
5.90%
发文量
87
期刊介绍: Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书